Publications by authors named "Minoru Fujimoto"

Claim this Profile
U
Umbilical Artery Leucine-Rich α-2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants.
Genichiro Sotodate, Satoshi Serada, Fumiaki Takahashi, Atsushi Matsumoto, Yukiko Toya, Minoru Fujimoto

Pediatr Pulmonol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells.
Takashi Yokouchi, Tsuyoshi Takahashi, Toshirou Nishida, Koji Tanaka, Yukinori Kurokawa, Minoru Fujimoto

Gastric Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.
Naoki Ikenaga, Tsuyoshi Takahashi, Koji Tanaka, Satoshi Serada, Minoru Fujimoto

Cancer Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Role for Leucine-Rich α2-Glycoprotein in Leukocyte Trafficking and Mucosal Inflammation in Inflammatory Bowel Disease.
Takashi Mishima, Minoru Fujimoto, Hayato Urushima, Eiji Funajima, Yuji Suzuki

Inflamm Bowel Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive score using umbilical vein leucine-rich α-2 glycoprotein as a useful biomarker for diagnosing histological chorioamnionitis in preterm infants.
Genichiro Sotodate, Satoshi Serada, Mitsumasa Osakabe, Fumiaki Takahashi, Atsushi Matsumoto, Minoru Fujimoto

J Obstet Gynaecol Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure.
Koji Saito, Minoru Fujimoto, Eiji Funajima, Satoshi Serada, Tomoharu Ohkawara

J Allergy Clin Immunol Glob· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancer.
Kota Kawabata, Tsuyoshi Takahashi, Koji Tanaka, Yukinori Kurokawa, Kazuyoshi Yamamoto, Minoru Fujimoto

Gastric Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis.
Minoru Fujimoto, Yuji Hosono, Satoshi Serada, Yuji Suzuki, Tomoharu Ohkawara

Mod Rheumatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Masashi Funauchi, Satoshi Serada, Kosuke Hiramatsu, Eiji Funajima, Mizuki Kanda, Minoru Fujimoto

Int J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumors.
Ryugo Teranishi, Tsuyoshi Takahashi, Yuuki Obata, Toshirou Nishida, Shuichi Ohkubo, Minoru Fujimoto

Int J Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody.
Yurina Saito, Tsuyoshi Takahashi, Kosuke Hiramatsu, Satoshi Serada, Minoru Fujimoto

Anticancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides.
Natsuka Umezawa, Fumitaka Mizoguchi, Yasuhiro Maejima, Naoki Kimura, Hisanori Hasegawa, Minoru Fujimoto

Front Med (Lausanne)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer.
Mizuki Kanda, Satoshi Serada, Kosuke Hiramatsu, Masashi Funauchi, Kengo Obata, Minoru Fujimoto

Neoplasia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung CCR6CXCR3 type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases.
Tsukie Kin Tsukuda, Hiroshi Ohnishi, Minoru Fujimoto, Yu Nakatani, Kazufumi Takamatsu

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.
Taihei Kajiyama, Satoshi Serada, Minoru Fujimoto, Tomoharu Ohkawara, Masahiro Komori

Anticancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
Kie Nakatani, Satoshi Serada, Minoru Fujimoto, Kengo Obata, Tomoharu Ohkawara

J Oral Pathol Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer.
Shigehiro Tsujii, Satoshi Serada, Minoru Fujimoto, Sunao Uemura, Tsutomu Namikawa

Mol Cancer Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model.
Hideki Nakajima, Kimiko Nakajima, Satoshi Serada, Minoru Fujimoto, Tetsuji Naka

Mod Rheumatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours.
Tomo Ishida, Tsuyoshi Takahashi, Yukinori Kurokawa, Toshirou Nishida, Seiichi Hirota, Minoru Fujimoto

Br J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.
Takahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, Minoru Fujimoto, Tomoharu Ohkawara

Oncotarget· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis.
Masahiro Koh, Tsuyoshi Takahashi, Yukinori Kurokawa, Teruyuki Kobayashi, Takuro Saito, Minoru Fujimoto

Gastric Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma.
Keiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, Keisuke Toya, Tsuyoshi Takahashi, Minoru Fujimoto

Mol Cancer Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
Eri Munekage, Satoshi Serada, Shigehiro Tsujii, Keiichiro Yokota, Keita Kiuchi, Minoru Fujimoto

Neoplasia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein.
Hideki Nakajima, Kimiko Nakajima, Mikiro Takaishi, Kentaro Ohko, Satoshi Serada, Minoru Fujimoto

J Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway.
Yusuke Takahashi, Satoshi Serada, Tomoharu Ohkawara, Minoru Fujimoto, Kosuke Hiramatsu

Biochem Biophys Res Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis